The short version
Only one company currently supplies this market — there is no backup if it stumbles.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Symbravo
meloxicam, rizatriptan · MELOXICAM 20 mg/1; RIZATRIPTAN BENZOATE 10 mg/1 · Tablet · Oral · Axsome Therapeutics, Inc.
NDC 81968-0020-03 · 1 BOTTLE in 1 CARTON / 3 TABLET in 1 BOTTLE · NDA · View full market →
Medicare Part D
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
90-day shortage risk (model v2)
0.0%chance of a new FDA shortage posting for meloxicam, rizatriptan (oral solid) in the next 90 days
For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.
Backtested statistical model over the whole market, not this package alone. Model details →
Where it's made
- api manufacture
- Patheon Inc.Canadamanufacture
- api manufacture
Establishments this product's FDA label declares, located via FDA registration data. How we built this →
Regulatory
- Application
- NDA215431
- TE code
- —
- Approval date
- Jan 30, 2025
- Patents / exclusivity
- 94 patents, 1 exclusivities
| Type | Number / code | Expires |
|---|---|---|
| exclusivity | NP | Jan 30, 2028 |
| patent | 12544383 | Mar 10, 2045 |
| patent | 12005118 | Jan 25, 2043 |
| patent | 12611413 | Dec 29, 2041 |
| patent | 12370196 | Dec 29, 2041 |
| patent | 12551489 | May 28, 2040 |
| patent | 12128052 | May 28, 2040 |
| patent | 12551488 | May 28, 2040 |
| patent | 12472257 | May 18, 2038 |
| patent | 12472256 | May 18, 2038 |
| patent | 12472258 | May 18, 2038 |
| patent | 12616752 | May 18, 2038 |
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of meloxicam, rizatriptan (Tablet)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Axsome Therapeutics, Inc. | MELOXICAM 20 mg/1; RIZATRIPTAN BENZOATE 10 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Symbravo — NDC 81968-0020-03," retrieved September 3, 2026, https://drugdashboards.com/drug/81968002003.
Free to cite with attribution — see how the data is put together.